BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 10827263)

  • 1. Results of HCV screening of volunteer blood donors with a chemiluminescent immunoassay and a second- or third-generation EIA: overlap of false-positive reactivity and its impact on donor management.
    Kiely P; Wilson D
    Transfusion; 2000 May; 40(5):580-4. PubMed ID: 10827263
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Follow-up of six blood donors highlights the complementary role and limitations of hepatitis C virus antibody and nucleic acid amplification tests.
    Hyland C; Seed CR; Kiely P; Parker S; Cowley N; Bolton W
    Vox Sang; 2003 Jul; 85(1):1-8. PubMed ID: 12823724
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acute hepatitis C virus seroconversion in a Scottish blood donor: HCV antigen is not comparable with HCV nucleic acid amplification technology screening.
    Dow BC; Munro H; Buchanan I; Ferguson K; Davidson F; Lycett C; Jarvis M; Cleland A; Petrik J; Lumley S; MacLean A
    Vox Sang; 2004 Jan; 86(1):15-20. PubMed ID: 14984555
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-HCV immunoblot indeterminate results in blood donors: non-specific reactivity or past exposure to HCV?
    Kiely P; Styles C
    Vox Sang; 2017 Aug; 112(6):542-548. PubMed ID: 28850195
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of low cost peptide-based anti-hepatitis C virus screening and confirmatory assays: comparison with commercially available tests.
    Palacios A; Taylor L; Haue L; Luftig RB; Visoná KA
    J Med Virol; 1999 Jul; 58(3):221-6. PubMed ID: 10447416
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatitis C antibody intraassay correlation: is retest in duplicate necessary?
    Contreras AM; Tinoco E; Celis A; Novelo B; Romero MV; Carrada E; Jiménez-Méndez R;
    Transfusion; 2007 Sep; 47(9):1686-90. PubMed ID: 17725735
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The significance of third-generation HCV RIBA-indeterminate, RNA-negative results in voluntary blood donors screened with sequential third-generation immunoassays.
    Kiely P; Kay D; Parker S; Piscitelli L
    Transfusion; 2004 Mar; 44(3):349-58. PubMed ID: 14996191
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Routine HCV PCR screening of blood donations to identify early HCV infection in blood donors lacking antibodies to HCV.
    Hitzler WE; Runkel S
    Transfusion; 2001 Mar; 41(3):333-7. PubMed ID: 11274586
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combination HCV core antigen and antibody assay on a fully automated chemiluminescence analyzer.
    Shah DO; Chang CD; Jiang LX; Cheng KY; Muerhoff AS; Gutierrez RA; Leary TP; Desai SM; Batac-Herman IV; Salbilla VA; Haller AS; Stewart JL; Dawson GJ
    Transfusion; 2003 Aug; 43(8):1067-74. PubMed ID: 12869112
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Significance of the signal-to-cutoff ratios of anti-hepatitis C virus enzyme immunoassays in screening of Chinese blood donors.
    Ren FR; Lv QS; Zhuang H; Li JJ; Gong XY; Gao GJ; Liu CL; Wang JX; Yao FZ; Zheng YR; Zhu FM; Tiemuer MH; Bai XH; Shan H
    Transfusion; 2005 Nov; 45(11):1816-22. PubMed ID: 16271110
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Confirmation of hepatitis C infection: a comparison of five immunoblot assays.
    Zaaijer HL; Vrielink H; van Exel-Oehlers PJ; Cuypers HT; Lelie PN
    Transfusion; 1994 Jul; 34(7):603-7. PubMed ID: 7519796
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Screening tests for hepatitis B virus, hepatitis C virus, and human immunodeficiency virus in blood donors: evaluation of two chemiluminescent immunoassay systems.
    Sommese L; Sabia C; Paolillo R; Parente D; Capuano M; Iannone C; Cavalca F; Schiano C; Vasco M; De Pascale MR; Casamassimi A; Napoli C
    Scand J Infect Dis; 2014 Sep; 46(9):660-4. PubMed ID: 25073538
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Role of the Signal-to-Cutoff Ratio in Automated Anti-HCV Chemiluminescent Immunoassays by Referring to the Nucleic Acid Amplification Test and the Recombinant Immunoblot Assay.
    Choi MS; Lee K; Hong YJ; Song EY; Kim DS; Song J
    Ann Lab Med; 2018 Sep; 38(5):466-472. PubMed ID: 29797818
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative yield of HCV RNA testing in blood donors screened by 2.0 versus 3.0 antibody assays.
    Galel SA; Strong DM; Tegtmeier GE; Holland PV; Kuramoto IK; Kemper M; Pietrelli L; Gallarda J
    Transfusion; 2002 Nov; 42(11):1507-13. PubMed ID: 12421226
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Third-generation hepatitis C virus tests in asymptomatic anti-HCV-positive blood donors.
    Craxì A; Valenza M; Fabiano C; Magrin S; Fiorentino G; Diquattro O; Pagliaro L
    J Hepatol; 1994 Nov; 21(5):730-4. PubMed ID: 7890886
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High rate of hepatitis C virus and human immunodeficiency virus false-positive results in serologic screening in sub-Saharan Africa: adverse impact on the blood supply.
    Candotti D; Sauvage V; Cappy P; Boullahi MA; Bizimana P; Mbensa GO; Oumar Coulibaly S; Rakoto Alson AO; Soumana H; Tagny-Tayou C; Murphy EL; Laperche S;
    Transfusion; 2020 Jan; 60(1):106-116. PubMed ID: 31777096
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnosis of hepatitis C virus in Brazilian blood donors using a reverse transcriptase nested polymerase chain reaction: comparison with enzyme immunoassay and recombinant protein immunoblot assay.
    Gonçales NS; Costa FF; Vassallo J; Gonçales FL
    Rev Inst Med Trop Sao Paulo; 2000; 42(5):263-7. PubMed ID: 11058936
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of overlapping synthetic peptides to characterize samples from blood donors with indeterminate results to hepatitis C virus core antigen.
    León P; López JA; Elola C; Lee SR; Calmann M; Echevarría JM
    Vox Sang; 1998; 75(1):32-6. PubMed ID: 9745151
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of the use of a combined HCV antigen/antibody assay in routine laboratory practice.
    Vermeersch P; Van Ranst M; Lagrou K
    Acta Clin Belg; 2010; 65(4):245-7. PubMed ID: 20954463
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence of hepatitis C virus and genotype distribution in an Australian volunteer blood donor population.
    Mison LM; Young IF; O'Donoghue M; Cowley N; Thorlton N; Hyland CA
    Transfusion; 1997 Jan; 37(1):73-8. PubMed ID: 9024493
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.